市場調查報告書

全球動物感染疾病診斷市場:各技術,動物,終端用戶,各地區 - 趨勢分析,競爭市場佔有率,及預測(2015年∼2025年)

Global Veterinary Infectious Disease Diagnostics Market by Technology (Immunodiagnostics, Molecular Diagnostics), Animal, End-User, By Region ; Trend Analysis, Competitive Market Share & Forecast, 2015-2025

出版商 Blueweave Consulting & Research Private Limited 商品編碼 924197
出版日期 內容資訊 英文 125 Pages
商品交期: 最快1-2個工作天內
價格
全球動物感染疾病診斷市場:各技術,動物,終端用戶,各地區 - 趨勢分析,競爭市場佔有率,及預測(2015年∼2025年) Global Veterinary Infectious Disease Diagnostics Market by Technology (Immunodiagnostics, Molecular Diagnostics), Animal, End-User, By Region ; Trend Analysis, Competitive Market Share & Forecast, 2015-2025
出版日期: 2019年11月05日內容資訊: 英文 125 Pages
簡介

全球動物感染疾病診斷市場在2019年∼2025年的預測期間內,預計將以超越8.2%的年複合成長率增長。專家和從業人員對常規診斷(例如核酸診斷,生物傳感器,PCR和生物標記)等先進動物傳染病診斷技術的需求不斷增長和採用,將推動市場增長並在預測期內產生積極影響。此外,與先進技術相關的好處,如快速,靈敏,準確的診斷,高效和準確的結果驗證,以及傳染病發病率的增加,有望推動未來的增長。

本報告提供全球動物感染疾病診斷市場的相關調查,提供市場機會和課題,成長及阻礙因素,各技術·動物類型·疾病類型·終端用戶·地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 調查架構

  • 調查目的
  • 產品概要
  • 市場區隔

第2章 調查方法

  • 質性調查
    • 第一手及第二手資料
  • 數量的調查
    • 第一手及第二手資料
  • 主要的調查受訪者的明細:各地區
    • 二次調查
    • 一次調查
  • 主要的調查受訪者的明細:各產業參與企業
  • 市場規模的估計
  • 調查的前提條件
  • 市場分析與資料三角測量

第3章 摘要整理

第4章 產業考察

  • DROC分析
    • 成長要素
    • 阻礙因素
    • 市場機會
    • 課題
  • 技術性預測
  • 法律規範
  • 企業的市場佔有率分析
  • 波特的五力分析
  • PEST分析
  • 策略性預測

第5章 市場概要

  • 市場規模與預測
    • 各銷售額
  • 市場佔有率與預測(2015年-2025年)
    • 各技術
    • 動物各類型
    • 各疾病類型
    • 各終端用戶
    • 各地區

第6章 北美市場

第7章 歐洲市場

第8章 亞太地區市場

第9章 南美市場

第10章 中東·非洲市場

第11章 企業簡介(企業概要,財務矩陣,主要產品的展望,主要員工,主要的競爭,聯絡處,策略性展望)

  • Biomerieux S.A.
  • Heska Corporation
  • IDEXX Laboratories, Inc.
  • IDVet
  • Neogen Corporation
  • QIAGEN N.V. (A Part of Indical Bioscience)
  • Randox Laboratories, Ltd.
  • Thermo Fisher Scientific
  • Virbac
  • Zoetis, Inc.
  • 其他的主要企業

第12章 策略性建議

目錄
Product Code: BWC19327

BlueWeave Consulting review study of the Global Veterinary Infectious Disease Diagnostics Market anticipated propelling with a significant CAGR of over 8.2% in the forecasted period of 2019-2025. Rising demand and adoption of advanced veterinary infectious disease diagnostic technologies by professionals and practitioners for routine diagnostic such as nucleic acid diagnostics, biosensors, PCR, and biomarkers driving the market growth and anticipated to witness the positive impact on the increase in upcoming years 2019-2025. Advantages associated with advanced technologies such as quick, sensitive & accurate diagnosis, high rate of efficacy, and accurate result validation coupled with the rising incidence of infectious diseases are anticipated to support the growth in upcoming years. North America is dominating the global market of veterinary infectious disease diagnostic with the presence of leading players in the North American region coupled with high healthcare spending for animals.

Growth in the companion animal population coupled with pet insurance expected to propel the growth of global veterinary infectious disease diagnostics market

In addition, rising investment in animal healthcare, increasing incidence of zoonotic diseases trend, rising disposable income in emerging economies coupled with veterinary practitioner's enhancement contributing simultaneously to drive the global veterinary infectious disease diagnostics and expected to witness commendable growth in upcoming years. The companion animal market witness significant growth owing to the increasing demand for animal products and animal protein. The companion animals such as cat and dog segment in the global veterinary infectious disease diagnostic market held a significant share in session 2018, owing to high expenditure on pet healthcare.

Non-infectious diseases anticipated to dominate the global veterinary infectious disease diagnostics market in the forecast period

Amidst the disease category non-infectious segment is anticipated to dominate the global veterinary infectious disease diagnostic market during the forecast period of 2091-2025. Advancement in technology such as chip technology for electrolytic imbalance analysis from the body fluid, hereditary, and acquired disease rise makes the market lucrative and anticipate to propel growth with a significant growth rate. Molecular screening contributing to the global market for the diagnosis of early-stage genetic disease and nanotechnology contribute via. screening of multiple pathogens in a single assay. Furthermore, the consumption of advanced analyzers for diagnostic purposes in veterinary hospitals has increased, which is aiding growth.

Veterinary infectious disease diagnostics market: competitive landscape

Some of the major industry players are Biomerieux S.A., Heska Corporation, IDEXX Laboratories, Inc., IDVet, Neogen Corporation, QIAGEN N.V. (A Part of Indical Bioscience), Randox Laboratories, Ltd., Thermo Fisher Scientific, Virbac, Zoetis, Inc. and Other Prominent Players

Don't miss the business opportunity of veterinary infectious disease diagnostics market. Consult to our analyst and gain crucial insights and facilitate your business growth.

The in-depth analysis of the report provides the growth potential, upcoming trends and statistics of veterinary infectious disease diagnostics market size & forecast. The report promises to provide state-of-the-art technology of veterinary infectious disease diagnostics market and industry insights which help decision makers to take sound strategic decisions. Furthermore, the report also analyzes the market drivers and challenges and competitive analysis of the market.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Research Methodology

  • 2.1. Qualitative Research
    • 2.1.1. Primary & Secondary Sources
  • 2.2. Quantitative Research
    • 2.2.1. Primary & Secondary Sources
  • 2.3. Breakdown of Primary Research Respondents, By Region
    • 2.3.1. Secondary Research
    • 2.3.2. Primary Research
  • 2.4. Breakdown of Primary Research Respondents, By Industry Participants
  • 2.5. Market Size Estimation
  • 2.6. Assumption for the Study
  • 2.7. Market Breakdown & Data Triangulation

3. Executive Summary

4. Global Veterinary Infectious Disease Diagnostics Market - Industry Insights

  • 4.1. DROC Analysis
    • 4.1.1. Growth Drivers
    • 4.1.2. Restraints
    • 4.1.3. Opportunities
    • 4.1.4. Challenges
  • 4.2. Technological Landscape
  • 4.3. Regulatory Framework
  • 4.4. Company Market Share Analysis,2018
  • 4.5. Porter's Five Forces Analysis
  • 4.6. Pest Analysis
  • 4.7. Strategic Outlook

5. Global Veterinary Infectious Disease Diagnostics Market Overview

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value (USD Million)
  • 5.2. Market Share & Forecast, 2015 - 2025
    • 5.2.1. By Technology
      • 5.2.1.1.1. Immunodiagnostics
      • 5.2.1.1.1.1. Lateral Flow Assays
      • 5.2.1.1.1.2. ELISA Tests
      • 5.2.1.1.1.3. Other Immunodiagnostic Technologies
      • 5.2.1.1.2. Molecular Diagnostics
      • 5.2.1.1.2.1. Polymerase Chain Reaction (PCR) Tests
      • 5.2.1.1.2.2. Microarrays
      • 5.2.1.1.2.3. Other Molecular Diagnostic Tests
    • 5.2.2. By Animal Type
      • 5.2.2.1. Companion Animals
      • 5.2.2.2. Food Producing Animals
    • 5.2.3. By Disease Type
      • 5.2.3.1. Infectious Diseases
      • 5.2.3.2. Non-infectious Diseases
      • 5.2.3.3. Hereditary, Congenital, and Acquired Diseases
      • 5.2.3.4. General Ailments
      • 5.2.3.5. Structural and Functional Diseases
    • 5.2.4. By End User
      • 5.2.4.1. Reference Laboratories
      • 5.2.4.2. Veterinary Laboratories and Clinics
      • 5.2.4.3. Point of Care / In House Testing
      • 5.2.4.4. Research Institutes and Universities
    • 5.2.5. By Region
      • 5.2.5.1. North America
      • 5.2.5.2. Europe
      • 5.2.5.3. Asia-Pacific
      • 5.2.5.4. Latin America
      • 5.2.5.5. Middle East and Africa

6. North America Veterinary Infectious Disease Diagnostics Market

  • 6.1. Market Estimates & Forecast, 2015 - 2025
    • 6.1.1. By Technology
    • 6.1.2. By Animal Type
    • 6.1.3. By Disease Type
    • 6.1.4. By End User
    • 6.1.5. By Country
      • 6.1.5.1. U.S
      • 6.1.5.2. Canada

7. Europe Veterinary Infectious Disease Diagnostics Market

  • 7.1. Market Estimates & Forecast, 2015 - 2025
    • 7.1.1. By Technology
    • 7.1.2. By Animal Type
    • 7.1.3. By Disease Type
    • 7.1.4. By End User
    • 7.1.5. By Country
      • 7.1.5.1. Germany
      • 7.1.5.2. U.K
      • 7.1.5.3. France
      • 7.1.5.4. Italy
      • 7.1.5.5. Rest of Europe

8. Asia-Pacific Veterinary Infectious Disease Diagnostics Market

  • 8.1. Market Estimates & Forecast, 2015 - 2025
    • 8.1.1. By Technology
    • 8.1.2. By Animal Type
    • 8.1.3. By Disease Type
    • 8.1.4. By End User
    • 8.1.5. By Country
      • 8.1.5.1. China
      • 8.1.5.2. India
      • 8.1.5.3. Japan
      • 8.1.5.4. Rest of APAC

9. Latin America Veterinary Infectious Disease Diagnostics Market

  • 9.1. Market Estimates & Forecast, 2015 - 2025
    • 9.1.1. By Technology
    • 9.1.2. By Animal Type
    • 9.1.3. By Disease Type
    • 9.1.4. By End User
    • 9.1.5. By Country
      • 9.1.5.1. Brazil
      • 9.1.5.2. Argentina
      • 9.1.5.3. Rest of Latin America

10. Middle East & Africa Veterinary Infectious Disease Diagnostics Market

  • 10.1. Market Estimates & Forecast, 2015 - 2025
    • 10.1.1. By Technology
    • 10.1.2. By Animal Type
    • 10.1.3. By Disease Type
    • 10.1.4. By End User
    • 10.1.5. By Country
      • 10.1.5.1. Saudi Arabia
      • 10.1.5.2. UAE
      • 10.1.5.3. South Africa
      • 10.1.5.4. Rest of MEA

11. Company Profiles (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook) *

  • 11.1. Biomerieux S.A.
  • 11.2. Heska Corporation
  • 11.3. IDEXX Laboratories, Inc.
  • 11.4. IDVet
  • 11.5. Neogen Corporation
  • 11.6. QIAGEN N.V. (A Part of Indical Bioscience)
  • 11.7. Randox Laboratories, Ltd.
  • 11.8. Thermo Fisher Scientific
  • 11.9. Virbac
  • 11.10. Zoetis, Inc.
  • 11.11. Other Prominent Player

12. Strategic Recommendation

  • Financial Details Not Be Captured in Case of Unlisted Companies
  • *The segmentation and the companies are subjected to modifications based on in-depth secondary for the final deliverable.